Invokana FDA Warning

The FDA safety communication issued a warning to the general public and the medical community that the agency is monitoring the side effects of SGLT2 inhibitors to determine whether changes need to be made in the prescribing protocol of the drug. The FDA wants patients to report any unusual side effects after starting the drug therapy to their doctors. Also, it urges medical providers and patients to report those side effects to the agency’s MedWatch program so the FDA can continue to monitor the possible dangers associated with the drug.

FDA Warning

If you or a loved one has experienced a harmful side effect while taking Invokana, you may be eligible to file a lawsuit. The lawyers at the Branch Law Firm are currently investigating claims that the inhibitor Invokana may be linked to an increased risk of ketoacidosis, heart failure, and possible stroke.

Please contact the Branch Law Firm at 1-800-828-4529 so one of our Albuquerque personal injury attorneys may review your claim.